These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15612413)

  • 1. Databases on biotechnology and biosafety of GMOs.
    Degrassi G; Alexandrova N; Ripandelli D
    Environ Biosafety Res; 2003; 2(3):145-60. PubMed ID: 15612413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically modified organisms: do the benefits outweigh the risks?
    Hug K
    Medicina (Kaunas); 2008; 44(2):87-99. PubMed ID: 18344661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical assessment of regulatory triggers for products of biotechnology: Product vs. process.
    McHughen A
    GM Crops Food; 2016 Oct; 7(3-4):125-158. PubMed ID: 27813691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genetically Modified Organism Medicinal Framework in Europe, United States, and Japan: Underlying Scientific Principles and Considerations Toward the Development of Gene Therapy and Genetically Modified Cell-Based Products.
    Bachtarzi H; Farries T
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):114-128. PubMed ID: 31111736
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversy over genetically modified organisms: the governing laws and regulations.
    Keatley KL
    Qual Assur; 2000; 8(1):33-6. PubMed ID: 11710306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case studies on the use of biotechnologies and on biosafety provisions in four African countries.
    Black R; Fava F; Mattei N; Robert V; Seal S; Verdier V
    J Biotechnol; 2011 Dec; 156(4):370-81. PubMed ID: 21763362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the OECD on the development of national/international risk/safety assessment frameworks.
    Gaugitsch H
    Environ Biosafety Res; 2006; 5(4):219-22. PubMed ID: 17640512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and Challenges for Implementation of the Common Market for Eastern and Southern Africa Policy on Biotechnology and Biosafety.
    Waithaka M; Belay G; Kyotalimye M; Karembu M
    Front Bioeng Biotechnol; 2015; 3():109. PubMed ID: 26284243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commercial Release of Genetically Modified Crops in Africa: Interface Between Biosafety Regulatory Systems and Varietal Release Systems.
    Akinbo O; Obukosia S; Ouedraogo J; Sinebo W; Savadogo M; Timpo S; Mbabazi R; Maredia K; Makinde D; Ambali A
    Front Plant Sci; 2021; 12():605937. PubMed ID: 33828569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of GMOs (genetically modified organisms): agricultural biotechnology or agricultural biopolitics?
    Nuti M; Felici C; Agnolucci M
    Riv Biol; 2007; 100(2):189-202. PubMed ID: 17987558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perception of GMOs by scientists and practitioners--the critical role of information flow about transgenic organisms.
    Małyska A; Maciąg K; Twardowski T
    N Biotechnol; 2014 Mar; 31(2):196-202. PubMed ID: 24316324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of the public and scientists to biotechnology in Japan at the start of 2000.
    Ng MA; Takeda C; Watanabe T; Macer D
    Eubios J Asian Int Bioeth; 2000 Jul; 10(4):106-13. PubMed ID: 16273712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transparent communication strategy on GMOs: will it change public opinion?
    Sinemus K; Egelhofer M
    Biotechnol J; 2007 Sep; 2(9):1141-6. PubMed ID: 17703492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotechnology and the American agricultural industry. Council on Scientific Affairs, American Medical Association.
    JAMA; 1991 Mar; 265(11):1429-36. PubMed ID: 1999885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current harmonization activities related to risk/safety assessment by the OECD Working Group on Harmonization of Regulatory Oversight in Biotechnology.
    MacDonald P; Yarrow S
    Environ Biosafety Res; 2006; 5(4):223-5. PubMed ID: 17640513
    [No Abstract]   [Full Text] [Related]  

  • 17. The emerging international regulatory framework for biotechnology.
    Komen J
    GM Crops Food; 2012; 3(1):78-84. PubMed ID: 22430851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations from the workshop on Comparative Approaches to Safety Assessment of GM Plant Materials: A road toward harmonized criteria?
    Bartholomaeus A; Batista JC; Burachik M; Parrott W
    GM Crops Food; 2015; 6(2):69-79. PubMed ID: 25706477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Need for an "integrated safety assessment" of GMOs, linking food safety and environmental considerations.
    Haslberger AG
    J Agric Food Chem; 2006 May; 54(9):3173-80. PubMed ID: 16637668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Governing GMOs in the USA: science, law and public health.
    Yang YT; Chen B
    J Sci Food Agric; 2016 Apr; 96(6):1851-5. PubMed ID: 26536836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.